- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 38.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35.28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.38M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $131K |
| Capex | Q1 2026 · Mar 31, 2025 | $45K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$10.45M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$15.24M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $10.57M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $7.93M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $10.57M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $7.93M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $15.19M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $16.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$26.61M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $17.74M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $90.95M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $47.6M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $91.97M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $50.8M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $50.34M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $51.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $78.34M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $81.25M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$3.80 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$3.80 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11.75M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $6.8M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.2M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.12M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$35.27M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$12.87M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.39M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$8.2M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $5.15M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $22.55M |